TP53, CDKN1A, and MDM2 mRNA levels remained unchanged by RAC1 knockdown, reinforcing the notion that the reduction in MM cell survival via Rac1 inhibition is independent of the p53 status (Figure 4A,B). This evidence concerns the gene MDM2 and Miyoshi myopathy.